THURSDAY, Sept. 28, 2023 (HealthDay News) – An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for ALS. Although the FDA isn’t bound by the votes of its advisory panels, agency scientists have already penned a scathing reviewContinue Reading

THURSDAY, Sept. 28, 2023 (HealthDay News) — New research shows that an antibiotic effective for bacterial pneumonia also appears to fight treatment-resistant staph infections. The drug is ceftobiprole. It appeared successful in fighting methicillin-resistant staph infections, sometimes called MRSA. It showed similar benefit when tested against the antibiotic daptomycin toContinue Reading

TUESDAY, Sept. 26, 2023 (HealthDay News) — Sweltering temperatures appear to fuel drug-related hospital visits, a problem that could be worsening with climate change, a new study suggests. “We saw that during periods of higher temperatures, there was a corresponding increase in hospital visits related to alcohol and substance use,Continue Reading